Patent details

Basic Information

Publication number:

92001

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP027648393

Legal Status:

Active

Application number:

92001

First applicant's nationality:

Procedural language:

French

Paediatric Extension

SPC Extension Filing Date:

31/10/2024

SPC Extension Agent Name:

OFFICE FREYLINGER S.A.

SPC Extension Status:

Pending & Published

SPC Extension Grant Date:

SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:

EU/1/11/736/001 - EDURANT - rilpivirine

Marketing Authorization Type:

Marketing Authorization Date:

28/11/2011

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

16/05/2012

First Marketing Authorization date:

28/11/2011

Grant date:

16/07/2012

Activation date:

09/08/2022

Publication date:

16/07/2012

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

28/11/2026

SPC Extension Expiration:

28/05/2027

Rejection date:

Withdrawal date:

Owner

From:

16/05/2012

 

 

Name:

Janssen Pharmaceutica NV

Address:

Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

16/05/2012

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

DE JONGE Marc René

Address:

Belgium (BE)

2

Name:

LEWI Paulus Joannes

Address:

Belgium (BE)

3

Name:

VINKERS Hendrik Maarten

Address:

Belgium (BE)

4

Name:

VAN AKEN Koen Jeanne Alfons

Address:

Belgium (BE)

5

Name:

PALANDJIAN Patrice

Address:

France (FR)

6

Name:

DAEYAERT Frederik Frans Desiré

Address:

Belgium (BE)

7

Name:

GUILLEMONT Jérôme Emile Georges

Address:

France (FR)

8

Name:

KOYMANS Lucien Maria Henricus

Address:

Belgium (BE)

9

Name:

HEERES Jan

Address:

Belgium (BE)

10

Name:

JANSSEN Paul Adriaan Jan

Address:

Belgium (BE)

Publication

Bulletin

1

Bulletin Heading:

SPCX1

Bulletin edition number:

2024/14

Publication date:

06/12/2024

Description:

Section G : Applications for extensions for pediatric use – I1E publication

2

Bulletin Heading:

SPC3

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

01/09/2025

Annual Fee Number:

24

Annual Fee Amount:

440 Euro

Expected Payer:

Last Annual Fee Payment Date:

26/07/2024

Last Annual Fee Paid Number:

23

Last Annual Fee Paid Amount:

430 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
04/11/2024	Publication	1
04/11/2024	FNET_DC_FRONTPAGE	1
31/10/2024	Summary of the product caracteristics	78
31/10/2024	Paediatric investigation plan	1
31/10/2024	Marketing authorization	3
31/10/2024	General Document	2
31/10/2024	Application Form	3
04/11/2024	Outgoing Correspondence	1